Cyclerion Therapeutics (CYCN) Accounts Payables (2018 - 2025)

Cyclerion Therapeutics' Accounts Payables history runs 8 years deep, the most recent figure standing at $508000.0 for Q4 2025.

• In Q4 2025, Accounts Payables rose 30.26% year-over-year to $508000.0; the TTM figure through Dec 2025 stood at $508000.0 (up 30.26% YoY), while the FY2025 annual figure was $508000.0, up 30.26% from the prior year.
• Accounts Payables was $508000.0 for Q4 2025 at Cyclerion Therapeutics, up from $480000.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $3.9 million in Q1 2023 to a low of $304000.0 in Q3 2024.
• Historically, Accounts Payables has averaged $1.4 million across 5 years, with a median of $1.1 million in 2021.
• The sharpest annual moves came in 2021 and 2024: Accounts Payables jumped 1755.93% in 2021, then plunged 81.12% in 2024.
• A 5-year view of Accounts Payables shows it stood at $1.8 million in 2021, then surged by 62.47% to $3.0 million in 2022, then plunged by 59.66% to $1.2 million in 2023, then slumped by 67.45% to $390000.0 in 2024, then surged by 30.26% to $508000.0 in 2025.
• The last three Accounts Payables figures came in at $508000.0 (Q4 2025), $480000.0 (Q3 2025), and $462000.0 (Q2 2025), per Business Quant data.